ArticleMolecular cancer therapeutics2016

A Novel Glycogen Synthase Kinase-3 Inhibitor Optimized for Acute Myeloid Leukemia Differentiation Activity.

Sophia Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.